|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1225 NEW YORK AVE. NW |
Address2 | 8th floor |
| City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 14108-12
|
||||||||
|
6. House ID# 300450000
|
||||||||
| TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Jane Sheehan |
Date | 7/17/2025 5:17:29 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Access to Fertility Treatment and Care ActAims tohelp individuals and families who are impacted by infertility.
Right to IVF Act Nationwide right to IVF and other assistive technologies
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jane |
Sheehan |
|
|
|
Jennifer |
Taylor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Keep Kids Covered ActContinuous eligibility (CE) nationwide for children with Medicaid and CHIP ages 0-6 and then for 24 months for children aged 6-19 (expanded from the current 12 month protection).
H.R. 1One Big Beautiful Bill Act"legislation that drops Medicaid coverage for adults who dont fulfill bureaucratic work reporting requirements; forces low-income adults off coverage by requiring them to re-apply every six months; rolls back retroactive coverage under the Medicaid and CHIP programs; repeals federal rules that streamlined eligibility and enrollment for the Medicare Savings Program and Medicaid/CHIP; makes it harder to get on and stay on ACA Marketplace plans by prohibiting use of current auto enrollment and renewal procedures; increases costs and reduce benefits in the ACA marketplaces; increases cost-sharing requirements for people enrolled in the Medicaid expansion; increases prescription drug costs by expanding Orphan Drug Exceptions in Medicare Drug Negotiation; eliminates premium assistance during income-based special enrollment period (SEP); eliminates limits on premium assistance pay-backs due to midyear income changes; increases premiums and cost-sharing for ACA marketplace plans; significantly restricts state use of provider taxes, a key tool for financing the state share of Medicaid; imposes new requirements on states for Medicaid provider taxes; restricts the use of State-Directed Payments; threatens federal money for key services by restricting funds from Section 1115
waivers; undoes increased FMAP for new expansion states; reduces federal Medicaid funds for certain states that use state dollars to cover residents who are not eligible for federally-funded Medicaid due to their immigration status; prohibits federal financial participation under Medicaid/CHIP for individuals with unverified citizenship; restricts Medicaid funding for Planned Parenthood clinics; further restricts federal funding for abortion services; prohibits federal Medicaid and CHIP funding for gender affirming care; rescinds Medicaid rules that keep nursing home residents safe; and cuts Medicare and ACA marketplace coverage for many lawfully present immigrants"
Legislation to advance site neutral payment reforms
Legislation to ensure fair billing practice for items and services furnished by off-campus hospital locations
a bill to task the Centers for Medicare & Medicaid Services (CMS) with establishing hybrid payments to reward primary care providers who provide the best care to their patients
H.R.4585Advancing Maternal Health Equity Under Medicaid Act"This bill provides a 90% federal matching rate for Medicaid maternal health care expenditures that exceed 2019 levels. Qualifying services must be provided by maternity care providers or perinatal health workers (e.g., doulas) and include prenatal and postpartum telehealth services, home visits, and behavioral health care.
S.1105No UPCODE ActA bill to amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jane |
Sheehan |
|
|
|
Jennifer |
Taylor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S.832/H.R.1492Ensuring Pathways to Innovative Cures ActToamend title XI of the Social Security Acttoequalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
H.R.946Orphan Cures ActTo amend title XI of the Social Security Act to expand and clarify the exclusion fororphandrugs under the Drug Price Negotiation Program.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jane |
Sheehan |
|
|
|
Jennifer |
Taylor |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |